Knott-David-M-Jr

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
84
Total Value
201745148
Accession Number
0001104659-25-047243
Form Type
13F-HR
Manager Name
Knott-David-M-Jr
Data Enrichment
93% identified
78 identified6 unidentified

Holdings

84 positions • $201.7M total value
Manager:
Search and click to pin securities to the top
Page 1 of 5
Calumet, Inc. /DE
Shares:3.3M
Value:$41.8M
% of Portfolio:20.7% ($41.8M/$201.7M)
Apollo Global Management, Inc.
Shares:225.0K
Value:$30.8M
% of Portfolio:15.3% ($30.8M/$201.7M)
47103U845
Shares:393.8K
Value:$20.0M
% of Portfolio:9.9% ($20.0M/$201.7M)
Alphabet Inc.
Shares:112.0K
Value:$17.5M
% of Portfolio:8.7% ($17.5M/$201.7M)
DocGo Inc.
Shares:3.1M
Value:$8.1M
% of Portfolio:4.0% ($8.1M/$201.7M)
Xeris Biopharma Holdings, Inc.
Shares:1.1M
Value:$6.1M
% of Portfolio:3.0% ($6.1M/$201.7M)
Verona Pharma plc
Shares:88.0K
Value:$5.6M
% of Portfolio:2.8% ($5.6M/$201.7M)
JPMORGAN CHASE & CO
Shares:21.0K
Value:$5.1M
% of Portfolio:2.6% ($5.1M/$201.7M)
CATALYST PHARMACEUTICALS, INC.
Shares:212.0K
Value:$5.1M
% of Portfolio:2.5% ($5.1M/$201.7M)
PFIZER INC
Shares:170.0K
Value:$4.3M
% of Portfolio:2.1% ($4.3M/$201.7M)
Travere Therapeutics, Inc.
Shares:228.0K
Value:$4.1M
% of Portfolio:2.0% ($4.1M/$201.7M)
Protagonist Therapeutics, Inc
Shares:76.0K
Value:$3.7M
% of Portfolio:1.8% ($3.7M/$201.7M)
BIOCRYST PHARMACEUTICALS INC
Shares:460.0K
Value:$3.5M
% of Portfolio:1.7% ($3.5M/$201.7M)
AVADEL PHARMACEUTICALS PLC
Shares:426.0K
Value:$3.3M
% of Portfolio:1.7% ($3.3M/$201.7M)
Enstar Group LTD
Shares:7.5K
Value:$2.5M
% of Portfolio:1.2% ($2.5M/$201.7M)
ARDELYX, INC.
Shares:493.8K
Value:$2.4M
% of Portfolio:1.2% ($2.4M/$201.7M)
OmniAb, Inc.
Shares:982.3K
Value:$2.4M
% of Portfolio:1.2% ($2.4M/$201.7M)
CSX CORP
Shares:70.0K
Value:$2.1M
% of Portfolio:1.0% ($2.1M/$201.7M)
ALLIANCEBERNSTEIN HOLDING L.P.
Shares:48.0K
Value:$1.8M
% of Portfolio:0.9% ($1.8M/$201.7M)
46090A721
Shares:70.5K
Value:$1.8M
% of Portfolio:0.9% ($1.8M/$201.7M)